An error occurred retrieving content to display, please try again.
Page not found (404)
Sorry - the page you requested could not be found.
Please choose a page from the navigation or try a website search above to find the information you need.
Toolkit
This trial found that in delivering cancer chemotherapy, centrally inserted totally implantable venous access devices had lower complication rates than centrally inserted tunnelled catheters, and lower rates than peripherally inserted central catheters.
1 Health Economics and Health Technology Assessment (HEHTA), Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK
2 Cancer Research UK Glasgow Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
3 School of Social Sciences, University of Dundee, Dundee, UK
4 Oncology, Northampton General Hospital, Northampton, UK
5 Intensive Care, Leeds Teaching Hospitals, Leeds, UK
6 Haematology, Newcastle Freeman Hospital, Newcastle upon Tyne, UK
7 Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK
8 Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK
* Corresponding author Email: olivia.wu@glasgow.ac.uk
Funding: {{metadata.Funding}}
{{metadata.Journal}} Volume: {{metadata.Volume}}, Issue: {{metadata.Issue}}, Published in {{metadata.PublicationDate | date:'MMMM yyyy'}}
https://doi.org/{{metadata.DOI}}
Citation: {{author}}{{ (($index < metadata.AuthorsArray.length-1) && ($index <=6)) ? ', ' : '' }}{{(metadata.AuthorsArray.length <= 6) ? '.' : '' }} {{(metadata.AuthorsArray.length > 6) ? 'et al.' : ''}} . {{metadata.JournalShortName}} {{metadata.PublicationDate | date:'yyyy'}};{{metadata.Volume}}({{metadata.Issue}})
Report Content
The full text of this issue is available as a PDF document from the Toolkit section on this page.
The full text of this issue is available as a PDF document from the Toolkit section on this page.
Responses to this report
No responses have been published.